Peter T. Harrison

Farnham, ENG GU97SX, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.

Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.

Journal: Acta neuropathologica
Published: October 13, 2025

Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-β pathology.

Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-β pathology.

Journal: Journal of neurology
Published: September 17, 2025

Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease.

Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain-Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease.

Journal: Journal of neurochemistry
Published: July 16, 2025

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease.

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease.

Journal: Neurology
Published: May 15, 2025

The potential dual role of tau phosphorylation: plasma phosphorylated-tau217 in newborns and Alzheimer's disease.

The potential dual role of tau phosphorylation: plasma phosphorylated-tau217 in newborns and Alzheimer's disease.

Journal: Brain communications
Published: February 27, 2025

Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity.

Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 04, 2025

Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia.

Brain-derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: December 02, 2024

Plasma p-tau212 as a biomarker of sporadic and Down Syndrome Alzheimer's disease.

Plasma p-tau212 as a biomarker of sporadic and Down Syndrome Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences
Published: November 22, 2024

Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease.

Plasma p-tau212 as a biomarker of sporadic and Down syndrome Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: November 05, 2024

Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.

Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.

Journal: medRxiv : the preprint server for health sciences
Published: January 03, 2024

A novel ultrasensitive assay for plasma p-tau217: performance in individuals with subjective cognitive decline and early Alzheimer's disease.

A novel ultrasensitive assay for plasma p-tau217: performance in individuals with subjective cognitive decline and early Alzheimer's disease.

Journal: medRxiv : the preprint server for health sciences
Published: October 24, 2023

A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.

A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 05, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026